152 related articles for article (PubMed ID: 30516998)
21. [18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP.
Ooms M; Attili B; Celen S; Koole M; Verbruggen A; Van Laere K; Bormans G
J Neurochem; 2016 Dec; 139(5):897-906. PubMed ID: 27664396
[TBL] [Abstract][Full Text] [Related]
22. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
[TBL] [Abstract][Full Text] [Related]
23. Phosphodiesterase 10A PET radioligand development program: from pig to human.
Plisson C; Weinzimmer D; Jakobsen S; Natesan S; Salinas C; Lin SF; Labaree D; Zheng MQ; Nabulsi N; Marques TR; Kapur S; Kawanishi E; Saijo T; Gunn RN; Carson RE; Rabiner EA
J Nucl Med; 2014 Apr; 55(4):595-601. PubMed ID: 24614221
[TBL] [Abstract][Full Text] [Related]
24. In Vivo Characterization of Two
Liu H; Jin H; Luo Z; Yue X; Zhang X; Flores H; Su Y; Perlmutter JS; Tu Z
ACS Chem Neurosci; 2018 May; 9(5):1066-1073. PubMed ID: 29400443
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of carbon-11 and fluorine-18 labeled tracers for in vivo visualization of PDE10A.
Ooms M; Celen S; Koole M; Langlois X; Schmidt M; De Angelis M; Andrés JI; Verbruggen A; Van Laere K; Bormans G
Nucl Med Biol; 2014 Sep; 41(8):695-704. PubMed ID: 25002365
[TBL] [Abstract][Full Text] [Related]
26. Development of a series of novel carbon-11 labeled PDE10A inhibitors.
Stepanov V; Miura S; Takano A; Amini N; Nakao R; Hasui T; Nakashima K; Taniguchi T; Kimura H; Kuroita T; Halldin C
J Labelled Comp Radiopharm; 2015 May; 58(5):202-8. PubMed ID: 25891816
[TBL] [Abstract][Full Text] [Related]
27. Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates.
Hwang DR; Hu E; Rumfelt S; Easwaramoorthy B; Castrillon J; Davis C; Allen JR; Chen H; Treanor J; Abi-Dargham A; Slifstein M
Nucl Med Biol; 2014 Apr; 41(4):343-9. PubMed ID: 24607437
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain.
Fujinaga M; Yamasaki T; Yui J; Hatori A; Xie L; Kawamura K; Asagawa C; Kumata K; Yoshida Y; Ogawa M; Nengaki N; Fukumura T; Zhang MR
J Med Chem; 2012 Mar; 55(5):2342-52. PubMed ID: 22316010
[TBL] [Abstract][Full Text] [Related]
29. Preclinical Characterization of the Phosphodiesterase 10A PET Tracer [(11)C]MK-8193.
Hostetler ED; Fan H; Joshi AD; Zeng Z; Eng W; Gantert L; Holahan M; Meng X; Miller P; O'Malley S; Purcell M; Riffel K; Salinas C; Williams M; Ma B; Buist N; Smith SM; Coleman PJ; Cox CD; Flores BA; Raheem IT; Cook JJ; Evelhoch JL
Mol Imaging Biol; 2016 Aug; 18(4):579-87. PubMed ID: 26596571
[TBL] [Abstract][Full Text] [Related]
30. Rapid identification of a novel small molecule phosphodiesterase 10A (PDE10A) tracer.
Hu E; Ma J; Biorn C; Lester-Zeiner D; Cho R; Rumfelt S; Kunz RK; Nixey T; Michelsen K; Miller S; Shi J; Wong J; Hill Della Puppa G; Able J; Talreja S; Hwang DR; Hitchcock SA; Porter A; Immke D; Allen JR; Treanor J; Chen H
J Med Chem; 2012 May; 55(10):4776-87. PubMed ID: 22548439
[TBL] [Abstract][Full Text] [Related]
31. Further evaluation of [11C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis.
Lin SF; Labaree D; Chen MK; Holden D; Gallezot JD; Kapinos M; Teng JK; Najafzadeh S; Plisson C; Rabiner EA; Gunn RN; Carson RE; Huang Y
Synapse; 2015 Feb; 69(2):86-95. PubMed ID: 25450608
[TBL] [Abstract][Full Text] [Related]
32. Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [¹¹C]MP-10 PET rodent imaging study with ex vivo confirmation.
Natesan S; Ashworth S; Nielsen J; Tang SP; Salinas C; Kealey S; Lauridsen JB; Stensbøl TB; Gunn RN; Rabiner EA; Kapur S
Transl Psychiatry; 2014 Apr; 4(4):e376. PubMed ID: 24690597
[TBL] [Abstract][Full Text] [Related]
33. 18F-FEAC and 18F-FEDAC: PET of the monkey brain and imaging of translocator protein (18 kDa) in the infarcted rat brain.
Yui J; Maeda J; Kumata K; Kawamura K; Yanamoto K; Hatori A; Yamasaki T; Nengaki N; Higuchi M; Zhang MR
J Nucl Med; 2010 Aug; 51(8):1301-9. PubMed ID: 20660373
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).
Wängler B; Schneider S; Thews O; Schirrmacher E; Comagic S; Feilen P; Schwanstecher C; Schwanstecher M; Shiue CY; Alavi A; Höhnemann S; Piel M; Rösch F; Schirrmacher R
Nucl Med Biol; 2004 Jul; 31(5):639-47. PubMed ID: 15219283
[TBL] [Abstract][Full Text] [Related]
35. Carbon-11 labeled papaverine as a PET tracer for imaging PDE10A: radiosynthesis, in vitro and in vivo evaluation.
Tu Z; Xu J; Jones LA; Li S; Mach RH
Nucl Med Biol; 2010 May; 37(4):509-16. PubMed ID: 20447563
[TBL] [Abstract][Full Text] [Related]
36. Radiosyntheses and in vivo evaluation of carbon-11 PET tracers for PDE10A in the brain of rodent and nonhuman primate.
Fan J; Zhang X; Li J; Jin H; Padakanti PK; Jones LA; Flores HP; Su Y; Perlmutter JS; Tu Z
Bioorg Med Chem; 2014 May; 22(9):2648-54. PubMed ID: 24721831
[TBL] [Abstract][Full Text] [Related]
37. Characterization of binding and inhibitory properties of TAK-063, a novel phosphodiesterase 10A inhibitor.
Harada A; Suzuki K; Kamiguchi N; Miyamoto M; Tohyama K; Nakashima K; Taniguchi T; Kimura H
PLoS One; 2015; 10(3):e0122197. PubMed ID: 25815469
[TBL] [Abstract][Full Text] [Related]
38. Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity.
Patel S; Knight A; Krause S; Teceno T; Tresse C; Li S; Cai Z; Gouasmat A; Carroll VM; Barret O; Gottmukkala V; Zhang W; Xiang X; Morley T; Huang Y; Passchier J
Mol Imaging Biol; 2020 Aug; 22(4):832-841. PubMed ID: 31728839
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of 2-(2'-((dimethylamino)methyl)-4'-(2-fluoroethoxy-substituted)phenylthio)benzenamine derivatives as potential positron emission tomography imaging agents for serotonin transporters.
Huang YY; Chang LT; Shen HY; Chen YH; Tzen KY; Shiue CY; Hsin LW
Bioorg Chem; 2020 Apr; 97():103654. PubMed ID: 32088418
[TBL] [Abstract][Full Text] [Related]
40. Fluorine-18 labeling and biodistribution studies on peroxisome proliferator-activated receptor-gamma ligands: potential positron emission tomography imaging agents.
Lee BC; Dence CS; Zhou H; Parent EE; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 2009 Feb; 36(2):147-53. PubMed ID: 19217526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
